RTP Mobile Logo
Select Publications

Abida W et al. Preliminary results from the TRITON2 study of rucaparib in patients with DNA damage repair-deficient metastatic castration-resistant prostate cancer: Updated analyses. ESMO Congress 2019;Abstract 846PD.

Barrett MT et al. Clinical study of genomic drivers in pancreatic ductal adenocarcinoma. Br J Cancer 2017;117(4):572-82. Abstract

Churi CR et al. Mutation profiling in cholangiocarcinoma: Prognostic and therapeutic implications. PLoS One 2014;9(12):e115383. Abstract

Girolami I et al. Programmed death-ligand 1 (PD-L1) is a potential biomarker of disease-free survival in papillary thyroid carcinoma: A systematic review and meta-analysis of PD-L1 immunoexpression in follicular epithelial derived thyroid carcinoma. Endocr Pathol 2020;31(3):291-300. Abstract

Khan SA et al. Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling. Head Neck 2019;41(6):1928-34. Abstract

Laha D et al. New therapies for advanced thyroid cancer. Front Endocrinol (Lausanne) 2020;11:82. Abstract

Lan X et al. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis. Cancer Sci 2020;111(6):2163-73. Abstract

Lowery MA et al. Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: Potential targets for intervention. Clin Cancer Res 2018;24(17):4154-61. Abstract

Ohshima K et al. Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors. Cancer Sci 2019;110(12):3821-33. Abstract

Shi E et al. FGFR1 and NTRK3 actionable alterations in “wild-type” gastrointestinal stromal tumors. J Transl Med 2016;14(1):339. Abstract

Tran TV et al. Evaluation of the expression levels of BRAF(V600E) mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay. BMC Cancer 2020;20(1):368. Abstract

Wardell CP et al. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 2018;68(5):959-69. Abstract

Willis J et al. Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel. Clin Cancer Res 2019;25(23):7035-45. Abstract

Xiao Q et al. Serum biomarkers for thyroid cancer. Biomark Med 2020;14(9):807-15. Abstract

Yoo SK et al. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer. Nat Commun 2019;10(1):2764. Abstract

Zhen DB et al. Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma. Semin Oncol 2018;45(3):107-15. Abstract